310 related articles for article (PubMed ID: 19785033)
1. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions.
Deeb O; Rosales-Hernández MC; Gómez-Castro C; Garduño-Juárez R; Correa-Basurto J
Biopolymers; 2010 Feb; 93(2):161-70. PubMed ID: 19785033
[TBL] [Abstract][Full Text] [Related]
2. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
Fujiwara S; Amisaki T
Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
[TBL] [Abstract][Full Text] [Related]
4. Binding of hydroxyquinoline probes to human serum albumin: combining molecular modeling and Förster's resonance energy transfer spectroscopy to understand flexible ligand binding.
Abou-Zied OK; Al-Lawatia N; Elstner M; Steinbrecher TB
J Phys Chem B; 2013 Jan; 117(4):1062-74. PubMed ID: 23297700
[TBL] [Abstract][Full Text] [Related]
5. Detergent binding as a sensor of hydrophobicity and polar interactions in the binding cavities of proteins.
Peyre V; Lair V; André V; le Maire G; Kragh-Hansen U; le Maire M; Møller JV
Langmuir; 2005 Sep; 21(19):8865-75. PubMed ID: 16142972
[TBL] [Abstract][Full Text] [Related]
6. Binding modes of flavones to human serum albumin: insights from experimental and computational studies.
Liu H; Bao W; Ding H; Jang J; Zou G
J Phys Chem B; 2010 Oct; 114(40):12938-47. PubMed ID: 20845951
[TBL] [Abstract][Full Text] [Related]
7. Results of molecular docking as descriptors to predict human serum albumin binding affinity.
Chen L; Chen X
J Mol Graph Model; 2012 Mar; 33():35-43. PubMed ID: 22153983
[TBL] [Abstract][Full Text] [Related]
8. Molecular interaction of human serum albumin with paracetamol: spectroscopic and molecular modeling studies.
Daneshgar P; Moosavi-Movahedi AA; Norouzi P; Ganjali MR; Madadkar-Sobhani A; Saboury AA
Int J Biol Macromol; 2009 Aug; 45(2):129-34. PubMed ID: 19409413
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of the drug-binding specificity of human serum albumin.
Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
[TBL] [Abstract][Full Text] [Related]
10. Temperature-dependent simultaneous ligand binding in human serum albumin.
Sinha SS; Mitra RK; Pal SK
J Phys Chem B; 2008 Apr; 112(16):4884-91. PubMed ID: 18386863
[TBL] [Abstract][Full Text] [Related]
11. Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin--an optical and NMR spectroscopic investigation.
Fanali G; Pariani G; Ascenzi P; Fasano M
FEBS J; 2009 Apr; 276(8):2241-50. PubMed ID: 19298387
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulation and binding studies of beta-sitosterol with human serum albumin and its biological relevance.
Sudhamalla B; Gokara M; Ahalawat N; Amooru DG; Subramanyam R
J Phys Chem B; 2010 Jul; 114(27):9054-62. PubMed ID: 20565066
[TBL] [Abstract][Full Text] [Related]
13. In vitro binding of leukotriene B4 (LTB4) to human serum albumin: evidence from spectroscopic, molecular modeling, and competitive displacement studies.
Zsila F; Bikádi Z; Lockwood SF
Bioorg Med Chem Lett; 2005 Aug; 15(16):3725-31. PubMed ID: 15993588
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of isoxazolcurcumin with human serum albumin: spectroscopic and molecular modeling studies.
Sahoo BK; Ghosh KS; Dasgupta S
Biopolymers; 2009 Feb; 91(2):108-19. PubMed ID: 18814316
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
16. Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.
Fanali G; Rampoldi V; di Masi A; Bolli A; Lopiano L; Ascenzi P; Fasano M
IUBMB Life; 2010 May; 62(5):371-6. PubMed ID: 20225277
[TBL] [Abstract][Full Text] [Related]
17. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.
Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B
J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067
[TBL] [Abstract][Full Text] [Related]
18. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
Pistolozzi M; Bertucci C
Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
Lucas LH; Price KE; Larive CK
J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793
[TBL] [Abstract][Full Text] [Related]
20. A protein-coated magnetic beads as a tool for the rapid drug-protein binding study.
Marszałł MP; Buciński A
J Pharm Biomed Anal; 2010 Jul; 52(3):420-4. PubMed ID: 19596536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
